Solarvest BioEnergy Inc. Announces Amended and Restated Interim Financial Statements and Management Discussion and Analysis f...

As a result of a review by the British Columbia Securities Commission ("BCSC"),
- SOLARVEST BIOENERGY INC (TSX VENTURE:SVS) ("Solarvest" or the "Company") is
issuing the following press release to clarify our disclosure. 


Solarvest today filed on SEDAR amended and restated interim financial
statements, together with an amended and restated Management Discussion and
Analysis ("MD&A"), for the period ended April 30, 2012. 


The BCSC has completed its review of the Company's interim financial statements
and MD&A for the three months ended April 30, 2012, which were originally filed
on June 29, 2012. The results of the review can be summarized as follows: the
amended and restated interim financial statements update the presentation of
certain information in compliance with IAS and IFRS requirements and now provide
additional disclosure with respect to the Company's operations, including
related party transactions, the commitment to issue shares as related to its
intellectual property development milestones and the ongoing analysis of the
value of its intellectual property. The amended and restated MD&A revises the
presentation of certain information in compliance with National Instrument
51-102 - Continuous Disclosure Obligations and now provides additional
disclosure with respect to research & development costs and related party
transactions. 


In addition, the Company has filed updated certificates of the Chief Executive
Officer and the Chief Financial Officer for the interim period ended April 30,
2012, as required under National Instrument 52-109 - Certification of Disclosure
in Issuers' Annual and Interim Filings.


About Solarvest: Solarvest is committed to the development of sustainable and
renewable energy sources to meet growing energy demands and environmental
challenges. Solarvest's intellectual property is a biologically-based hydrogen
producing technology, which provides a method for controlling key genes in algae
resulting in the continuous production of hydrogen gas. Solarvest's bio-energy
production system utilizes light and carbon dioxide to produce hydrogen leaving
a clean positive environmental footprint.


The statements made in this news release may contain forward-looking statements
that may involve a number of risks and uncertainties. Actual events or results
could differ materially from the Company's expectations and projections.

Solarvest BioEnergy (TSXV:SVS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024